Literature DB >> 11731948

"Endgame" issues for the global polio eradication initiative.

.   

Abstract

The polio eradication initiative, created after the World Health Assembly resolved, in 1988, to eradicate poliomyelitis globally by 2000, has made remarkable progress. From 1988 through 2000, the number of countries where polio was endemic decreased from >125 to 20, and the estimated number of polio cases decreased from 350,000 to <3500, for a percentage decrease of >99%. Wild-type 2 poliovirus has not been detected worldwide since October 1999, despite improving surveillance. The major focus of the eradication effort is to complete the task of stopping wild-type poliovirus transmission. Given the rapid progress made toward this goal, planning for the posteradication era has begun in earnest (1) to minimize the risk of reintroduction of virus into the population from laboratory stocks or long-term carriers, and (2) to prevent vaccine-derived polioviruses from circulating and causing outbreaks. This report summarizes the current thinking about these "endgame" issues, as put forth by the World Health Organization's technical advisory body for the initiative, the Technical Consultative Group on the Global Eradication of Poliomyelitis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11731948     DOI: 10.1086/338262

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  18 in total

1.  Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993.

Authors:  Chen-Fu Yang; Tary Naguib; Su-Ju Yang; Eman Nasr; Jaume Jorba; Nahed Ahmed; Ray Campagnoli; Harrie van der Avoort; Hiroyuki Shimizu; Tetsuo Yoneyama; Tatsuo Miyamura; Mark Pallansch; Olen Kew
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

2.  Multiplex PCR method for identifying recombinant vaccine-related polioviruses.

Authors:  David R Kilpatrick; Karen Ching; Jane Iber; Ray Campagnoli; Christopher J Freeman; Nada Mishrik; Hong-Mei Liu; Mark A Pallansch; Olen M Kew
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

3.  Retrospective analysis of a local cessation of vaccination against poliomyelitis: a possible scenario for the future.

Authors:  Ekaterina A Korotkova; Renee Park; Elena A Cherkasova; Galina Y Lipskaya; Konstantin M Chumakov; Esfir V Feldman; Olen M Kew; Vadim I Agol
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

4.  Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001.

Authors:  Hiroyuki Shimizu; Bruce Thorley; Fem Julia Paladin; Kerri Anne Brussen; Vicki Stambos; Lilly Yuen; Andi Utama; Yoshio Tano; Minetaro Arita; Hiromu Yoshida; Tetsuo Yoneyama; Agnes Benegas; Sigrun Roesel; Mark Pallansch; Olen Kew; Tatsuo Miyamura
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

5.  Microbe hunting in the 21st century.

Authors:  W Ian Lipkin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-31       Impact factor: 11.205

6.  The risks, costs, and benefits of possible future global policies for managing polioviruses.

Authors:  Kimberly M Thompson; Radboud J Duintjer Tebbens; Mark A Pallansch; Olen M Kew; Roland W Sutter; R Bruce Aylward; Margaret Watkins; Howard E Gary; James Alexander; Hamid Jafari; Stephen L Cochi
Journal:  Am J Public Health       Date:  2008-05-29       Impact factor: 9.308

7.  Synthesizing epidemiological and economic optima for control of immunizing infections.

Authors:  Petra Klepac; Ramanan Laxminarayan; Bryan T Grenfell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

8.  Genomic analysis of recombinant sabin clinical isolates.

Authors:  Eleni Paximadi; Ioannis Karakasiliotis; Zissis Mamuris; Constantinos Stathopoulos; Vassilis Krikelis; Panayotis Markoulatos
Journal:  Virus Genes       Date:  2006-04       Impact factor: 2.332

9.  Baseline patterns of bone scintigraphy in patients with established post-poliomyelitis paralysis.

Authors:  Fahad A Marafi; Ali Al-Said Ali; Abdulredha A Esmail; Abdelhamid H Elgazzar
Journal:  Skeletal Radiol       Date:  2009-07-11       Impact factor: 2.199

10.  Limited duration of vaccine poliovirus and other enterovirus excretion among human immunodeficiency virus infected children in Kenya.

Authors:  Nino Khetsuriani; Rita Helfand; Mark Pallansch; Olen Kew; Ashley Fowlkes; M Steven Oberste; Peter Tukei; Joseph Muli; Ernest Makokha; Howard Gary
Journal:  BMC Infect Dis       Date:  2009-08-23       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.